Enoxaparin vs. nadroparin for venous thromboembolism prevention: too close to tell?
- PMID: 16879210
- DOI: 10.1111/j.1538-7836.2006.02084.x
Enoxaparin vs. nadroparin for venous thromboembolism prevention: too close to tell?
Comment on
-
A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancer.J Thromb Haemost. 2006 Aug;4(8):1693-700. doi: 10.1111/j.1538-7836.2006.02083.x. Epub 2006 Jun 21. J Thromb Haemost. 2006. PMID: 16796710 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
